Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.
2.

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N.

Health Technol Assess. 2004 Oct;8(43):iii, 1-171. Review.

3.

Diabetes management in the new millennium using insulin pump therapy.

Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC.

Diabetes Metab Res Rev. 2002 Jan-Feb;18 Suppl 1:S14-20. Review.

PMID:
11921425
4.

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

Pickup JC, Renard E.

Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. doi: 10.2337/dc08-s235. Review.

PMID:
18227475
6.
8.

The use of insulin pump therapy in the pediatric age group.

Shalitin S, Phillip M.

Horm Res. 2008;70(1):14-21. doi: 10.1159/000129673. Epub 2008 May 21. Review.

9.

Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review.

Churchill JN, Ruppe RL, Smaldone A.

J Pediatr Health Care. 2009 May-Jun;23(3):173-9. doi: 10.1016/j.pedhc.2008.07.002. Epub 2008 Aug 23. Review.

PMID:
19401250
10.

Cost-effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion?

Nuboer R, Bruining GJ.

Pediatr Diabetes. 2006 Aug;7 Suppl 4:39-44. Review.

PMID:
16774617
12.

Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.

Weintrob N, Shalitin S, Phillip M.

Isr Med Assoc J. 2004 May;6(5):271-5. Review.

13.

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.

Kaiserman K, Rodriguez H, Stephenson A, Wolka L, Fahrbach JL.

Endocr Pract. 2012 May-Jun;18(3):418-24. doi: 10.4158/EP11265.RA. Review.

PMID:
22297055
14.

Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.

Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM.

J Clin Endocrinol Metab. 2009 Mar;94(3):729-40. doi: 10.1210/jc.2008-1415. Epub 2008 Dec 16. Review.

PMID:
19088167
15.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
16.
17.

[Insulin pump therapy in patients with type 1 diabetes].

Minicucci WJ.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):340-8. Review. Portuguese.

18.

Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes.

Reznik Y.

Diabetes Metab. 2010 Dec;36(6 Pt 1):415-21. doi: 10.1016/j.diabet.2010.08.002. Review.

PMID:
20888280
19.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
20.

Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.

Pitocco D, Rizzi A, Scavone G, Tanese L, Zaccardi F, Manto A, Ghirlanda G.

Minerva Endocrinol. 2013 Sep;38(3):321-8. Review.

PMID:
24126552

Supplemental Content

Support Center